‹ DBD latest research

DBD (Diebold Nixdorf Incorporated): every AI call and what happened next

TradeFlare's AI research teams analysed DBD on 3 market nights between May 25, 2026 and August 5, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

3 calls 3 BUY · 0 HOLD · 0 SELL BUY calls up after 20 trading days: 1 of 3
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
August 5, 2026 BUY $76.84 $83.05 / $66.76 -8.1% -13.4%
The insider buying is a strong signal, but the technicals and risk profile suggest a longer-term accumulation play.
August 3, 2026 BUY $73.59 — / — -7.5% -12.4%
Strong analyst consensus with a mean target price of $98.33, suggesting significant upside potential.
May 25, 2026 BUY $74.30 $88.27 / $66.20 +3.5% +5.0%
The insider buying signal suggests a longer-term conviction, and the fundamental analysis points to significant upside potential that will likely take time to materialize.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.